State Street’s Armata Pharmaceuticals ARMP Stock Holding History

State Street’s Portfolio ARMP Stock Details ARMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$840K	Buy	129,600 +78,800	+155%	+$723K	﹤0.01%	3488
2026 Q1	$520K	Hold	50,800	–	–	﹤0.01%	3646
2025 Q4	$319K	Buy	50,800 +10,500	+26%	+$57.5K	﹤0.01%	3794
2025 Q3	$120K	Hold	40,300	–	–	﹤0.01%	4021
2025 Q2	$76.6K	Hold	40,300	–	–	﹤0.01%	4021
2025 Q1	$58.8K	Hold	40,300	–	–	﹤0.01%	4069
2024 Q4	$74.6K	Hold	40,300	–	–	﹤0.01%	4054
2024 Q3	$95.5K	Hold	40,300	–	–	﹤0.01%	3986
2024 Q2	$111K	Hold	40,300	–	–	﹤0.01%	3977
2024 Q1	$168K	Hold	40,300	–	–	﹤0.01%	3912
2023 Q4	$131K	Hold	40,300	–	–	﹤0.01%	3996
2023 Q3	$121K	Buy	+40,300	New	+$108K	﹤0.01%	4067

Other funds holding ARMP

MAM

Madison Asset Management Madison, Wisconsin $8.39B AUM 16.36% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

DIG

Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Edgewood Management Greenwich, Connecticut $9.69B AUM 6.52% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

State Street's ARMP Position: Q2 2026 in Review

State Street increased its Armata Pharmaceuticals (ARMP) stake by 155% in Q2 2026, buying an estimated $723K and bringing the position to 129,600 shares worth $840K. The position accounts for ﹤0.01% of the portfolio, ranked #3488.

State Street first reported a position in ARMP in Q3 2023 and has held it in 12 quarters since. 53 funds tracked by Wall St. Rank hold ARMP as of Q2 2026.

State Street held 129,600 shares of Armata Pharmaceuticals worth $840K as of Q2 2026.
State Street bought 78,800 Armata Pharmaceuticals shares in Q2 2026, an estimated $723K.
Armata Pharmaceuticals made up ﹤0.01% of State Street's portfolio in Q2 2026, its #3488 holding.
State Street first reported a position in Armata Pharmaceuticals in Q3 2023 and has held it in 12 quarters since.
53 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q2 2026.

Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.